CFM
JAZZ icon

Capricorn Fund Managers’s Jazz Pharmaceuticals JAZZ Stock Holding History

Capricorn Fund Managers’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Buy
+6,100
New +$1.34M 0.12% 129
2026
Q1 		– Sell
-10,000
Closed -$1.7M – 131
2025
Q4 		$1.7M Buy
+10,000
New +$1.53M 0.41% 60

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Capricorn Fund Managers's JAZZ Position: Q2 2026 in Review

Capricorn Fund Managers opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 6,100 shares worth $1.47M. The stake represents 0.12% of the portfolio and ranks #129 among its holdings. This is a return to the name: Capricorn Fund Managers previously reported a position in JAZZ as recently as Q4 2025.

Capricorn Fund Managers first reported a position in JAZZ in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.7M in Q4 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Capricorn Fund Managers held 6,100 shares of Jazz Pharmaceuticals worth $1.47M as of Q2 2026.
  • Jazz Pharmaceuticals was a new Capricorn Fund Managers position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.12% of Capricorn Fund Managers's portfolio in Q2 2026, its #129 holding.
  • Capricorn Fund Managers first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Capricorn Fund Managers's Jazz Pharmaceuticals position peaked at $1.7M in Q4 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.